MRC CiC: A new technique to measure minimal residual disease in myeloma that offers superior sensitivity, reduced cost and patient benefits

    Project Details

    Short titleMRC CiC: A new technique to measure minimal residual disease in myeloma that offers superior sensitivity, reduced cost and patient benefits
    StatusFinished
    Effective start/end date1/03/20 → 30/09/21

    Funding

    • Medical Research Council